Josh Wolfe

Partner, Co-Founder of Lux Capital

📍 New York City Metropolitan Area, United States🔄 Updated September 2026💼 19 investments📅 23 years investing🗓 Last invested Jan 2015𝕏 @upgrade_to_unlock
VC🌍 United States
19
Total investments
10
Early stage
2
Mid stage
1
Late stage
23y
Years active

Portfolio

17 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
2015
At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases. Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease. Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development. Together, we are leveraging multiple sophisticated technologies and internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health.
Board Member
2014
3Scan is turning tissue biology and histopathology into data science, giving researchers the insights they need to break new ground. A one-stop shop for digital and computational pathology, 3Scan’s KESM produces digital 3D tissue models with micron-scale resolution at 400 times the throughput of traditional microscopes. 3Scan’s data platform enables quantitative image analysis of diseases like cancer, Parkinson’s, Alzheimer’s, and Huntington’s, opening up the potential for new diagnostic and therapeutic solutions. Founded by Todd Huffman, Megan Klimen, Matthew Goodman, and Cody Daniel in San Francisco in 2011, 3Scan’s team of engineers, biologists and data-scientists is expanding its work into a suite of digital tools that will allow instant identification and classification of histopathologic features and tissue structures.
Investor
2013
Compass is a real estate technology company with a powerful end-to-end platform that supports the entire buying and selling workflow. We deliver an incomparable experience to both agents and their clients all in service of the Compass mission: to help everyone find their place in the world. Founded in 2012 by Ori Allon and Robert Reffkin, Compass operates in 22+ regions across the United States including New York, Los Angeles and Orange County, Chicago, San Francisco, Boston, Washington D.C., South Florida, The Hamptons, Santa Barbara & Montecito, San Diego, Seattle & Eastside, Philadelphia, Connecticut, Westchester, Aspen, Boulder, Denver, Atlanta, Austin & Central Texas, Dallas-Fort Worth, Houston, Nashville, and Lake Tahoe. Learn more and find your place at www.compass.com and www.compass.com/careers. Compass only reaches out to applicants from a @compass.com domain and does not prompt applicants to download software or files as part of its application process.
early stageReal Estate
Investor
2013
At Matterport, were on a mission to unlock the full potential of properties for our customers. With our state-of-the-art 3D digital twin solutions and AI-powered property insights, we revolutionize every phase of the building lifecycle.
Board Member, Founding Investor
2012
Kymeta is the leader in unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Kymeta’s satellite connectivity solutions offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for low-power, low-cost and high-throughput communication systems that have no moving parts. Kymeta makes connecting easy – for any vehicle, vessel, aircraft, or fixed platform. Kymeta is a privately held company based in Redmond, Washington. For more information, visit kymetacorp.com.
Investor
Apr 2009
Luxtera’s silicon photonics technology transforms how the world connects through fiber optics. Luxtera, Inc., is the world leader in Silicon Photonics. It is the first company to overcome the complex technical obstacles involved with integrating high performance optics directly with silicon electronics on a mainstream CMOS chip, bringing direct “fiber to the chip” connectivity to market.
Investor
Apr 2008
Salesconx helps companies of all sizes attain the sales coverage they are seeking by leveraging a nationwide network of sales and business professionals who deliver rapid and relevant results on demand. Our network of the top sales experts in the country working as virtual sales teams can cost effectively deliver sales results. These virtual sales teams are easily replenished and adjusted on an ongoing basis without the frictions associated with terminating and establishing relationships. In addition, the teams are pay-for-performance so their results are easily measured. Our platform launched in January 2008 is secure, easy to use and field tested with thousands of transactions across hundreds of clients.
Investor, Board Observer
Jan 2007
Siluria Technologies is pioneering the commercial production of fuels and chemicals made from clean, abundant natural gas. Siluria’s break through Oxidative Coupling of Methane ("OCM"​) process technology is believed to be the first commercially viable process to directly convert methane to ethylene. Siluria’s second process technology can convert ethylene to liquid fuels such as gasoline, diesel or jet fuel. This enables natural gas to potentially supplement petroleum as the worldwide basis for transportation fuels and commodity chemicals. Siluria’s revolutionary catalyst and process technologies uniquely combine nanomaterials, templating and chemical engineering, to convert natural gas into higher value products using efficient processes that can be seamlessly integrated into existing industry infrastructure. Siluria has assembled a world-class team of management, analysts, scientists and engineers. We are always on the lookout for talented individuals who are looking to contribute to groundbreaking R&D and engineering innovations in the energy industry. If you are interested in working with Siluria please visit our career’s page at: https://www.theapplicantmanager.com/careers?co=si. You are welcome to submit your resume even If no positions (of interest to you) are posted but please note that we will only accept and consider applications submitted through our career’s page. If you are a recruiter and interested in working with Siluria Technologies, please contact our HR Director. Siluria does not accept unsolicited resumes submitted by recruiters and/or recruiting companies. Equal Employment Opportunity: Siluria Technologies Inc. is an Equal Employment Opportunity employer - Minorities/Female/Veterans/Disabled.  Our Company provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, sexual orientation, gender identity, genetics, disability or protected veteran status.  In addition to federal law requirements, Siluria complies with applicable state and local laws governing nondiscrimination in employment in every location in which the company has facilities.  It is the policy of Siluria Technologies, Inc. to take voluntary, positive action in providing affirmative action and equal employment opportunity to individuals with disabilities and protected veterans. All personnel actions, including compensation, benefits, recruitment, hiring, training, and promoting persons in all job titles, will be administered without regard to disability or protected veteran status, and all employment decisions are based solely on valid job requirements.  A copy of our Equal Employment Opportunity statement which reaffirms our commitment to qualified individuals with disabilities and protected veterans is posted at: http://www.siluria.com/admin/kcfinder/upload/files/Siluria%20Technologies%20EEO%20Policy%202017.pdf. Should an employee or applicant request the policy be made available in an alternative format that is accessible and understandable to them, it shall be provided. 
early stageOil and Gas
Board Member
Aug 2006
Crystal IS, an Asahi Kasei company, is an innovative U.S.-based manufacturer of proprietary, high-performance UVC LEDs. Our Klaran line of UVC LEDs are suitable for water, surface and air disinfection in a variety of applications, including consumer and commercial appliances, medical devices and equipment, life sciences and more. Our Optan line of UVC LEDs can be used in water quality monitoring, air and gas sensing and instrumentation applications. Crystal IS powerful and reliable UVC LEDs give customers the flexibility to develop new products that enhance and sustain life. Crystal IS has achieved ISO 9001:2015 certification. For more information about Crystal IS, visit cisuvc.com For more information about Klaran, visit klaran.com
late stageSemiconductors
co-founder, investor
Aug 2006
Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS™, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.
early stageBiotechnology
Investor
Feb 2004
Molecular Imprints Inc. (MII), the market and technology leader for nanopatterning systems and solutions uses its innovative Jet and FlashTM Imprint Lithography (J-FILTM) technology to provide high-resolution, low cost-of-ownership nanopatterning capability for flat panel display, hard disk drive industries, light emitting diodes, life science and other high tech industries.
Investor
Jan 2004
Cambrios is the leader in silver nanowire solutions to enable the development of electronic devices with transparent conductors. Our proprietary nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components at lower manufacturing cost. ClearOhm™, our first product, is a directly patternable, wet-processable transparent conductive film made from silver nanowires that is poised to replace the industry standard sputtered indium tin oxide (ITO). Subsequent products will leverage this technology to produce other functional films for display and thin film applications for multiple consumer electronic device markets.
Show all 17 investments ↓
Experience · 24 entries
All (24)
Investments (17)
Founder (6)
Board (6)
2015
Board Member
2015
At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases. Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease. Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development. Together, we are leveraging multiple sophisticated technologies and internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health.
2014
Board Member
2014
3Scan is turning tissue biology and histopathology into data science, giving researchers the insights they need to break new ground. A one-stop shop for digital and computational pathology, 3Scan’s KESM produces digital 3D tissue models with micron-scale resolution at 400 times the throughput of traditional microscopes. 3Scan’s data platform enables quantitative image analysis of diseases like cancer, Parkinson’s, Alzheimer’s, and Huntington’s, opening up the potential for new diagnostic and therapeutic solutions. Founded by Todd Huffman, Megan Klimen, Matthew Goodman, and Cody Daniel in San Francisco in 2011, 3Scan’s team of engineers, biologists and data-scientists is expanding its work into a suite of digital tools that will allow instant identification and classification of histopathologic features and tissue structures.
2013
Investor
2013
Compass is a real estate technology company with a powerful end-to-end platform that supports the entire buying and selling workflow. We deliver an incomparable experience to both agents and their clients all in service of the Compass mission: to help everyone find their place in the world. Founded in 2012 by Ori Allon and Robert Reffkin, Compass operates in 22+ regions across the United States including New York, Los Angeles and Orange County, Chicago, San Francisco, Boston, Washington D.C., South Florida, The Hamptons, Santa Barbara & Montecito, San Diego, Seattle & Eastside, Philadelphia, Connecticut, Westchester, Aspen, Boulder, Denver, Atlanta, Austin & Central Texas, Dallas-Fort Worth, Houston, Nashville, and Lake Tahoe. Learn more and find your place at www.compass.com and www.compass.com/careers. Compass only reaches out to applicants from a @compass.com domain and does not prompt applicants to download software or files as part of its application process.
early stageReal Estate
Investor
2013
At Matterport, were on a mission to unlock the full potential of properties for our customers. With our state-of-the-art 3D digital twin solutions and AI-powered property insights, we revolutionize every phase of the building lifecycle.
2012
Board Member, Founding Investor
2012
Kymeta is the leader in unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Kymeta’s satellite connectivity solutions offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for low-power, low-cost and high-throughput communication systems that have no moving parts. Kymeta makes connecting easy – for any vehicle, vessel, aircraft, or fixed platform. Kymeta is a privately held company based in Redmond, Washington. For more information, visit kymetacorp.com.
Show all 24 entries ↓
Investment activity
2003–2015 · 19 investments
20032200422006220075200822009120121201322014120151
Recent (last 2 years)Earlier